Cardiac Arrhythmia Monitoring Devices Market Size and Trends

The global cardiac arrhythmia monitoring devices market size is expected to reach US$ 13.80 Bn by 2030, from US$ 8.13 Bn in 2023, at a CAGR of 7.8% during the forecast period. Cardiac arrhythmia monitoring devices are used to detect irregular heart rhythms and monitor heart activity. These devices include resting ECG devices, ECG stress test devices, mobile cardiac telemetry monitors, implantable cardiac monitors, holter monitors, and event monitors among others. The rising prevalence of cardiac diseases and favorable reimbursement policies are the key drivers of market growth.

The cardiac arrhythmia monitoring devices market is segmented by product type, end user, application, and region. By product type, the resting ECG devices segment accounted for the largest share of the market in 2022. Resting ECG devices are portable and easy-to-use for diagnosis of heart conditions, making them a commonly adopted product.

Global Cardiac Arrhythmia Monitoring Devices Market Trends:

Shift towards remote patient monitoring: A major trend in the market is the increasing utilization of remote cardiac monitoring services for better arrhythmia management and care coordination. Advanced devices integrated with wireless connectivity allow data transmission to mobile apps and online portals accessible to physicians. This enables timely interventions based on remote ECG analysis. Players are forming partnerships to offer comprehensive RPM services.
Growing adoption of mobile cardiac telemetry: The adoption of mobile cardiac telemetry (MCT) monitors is rising owing to their ability to provide real-time monitoring for fast arrhythmia detection. MCT devices comprise a small sensor attached to electrodes that wirelessly transmits ECG data to a portable recorder. This enhances monitoring for temporarily high-risk ambulatory patients. The launch of new advanced MCT monitors is supporting this growing trend.
Technological innovations in smart wearable: Key players are innovating smart wearable products such as ECG-enabled patches, shirts, watches that use advanced sensors and AI to continuously monitor heart activity. For instance, the new Carnation Ambulatory Monitor by Vivalnk, provider of remote patient monitoring services through innovative technology features a machine-learning algorithm to detect arrhythmias from ECG data. Such innovations are enabling long-term cardiac monitoring through consumer wearable.
Shift towards preventive and personalized care: There is a rising trend of using cardiac arrhythmia monitoring devices, such as injectable cardiac monitors (ICMs) and ambulatory ECG, for preventive care in high-risk groups. The use of advanced ECG analytics and digital platforms is also rising to enable monitoring of asymptomatic events and provide individualized care based on patients’ specific needs. This shift towards preventive and personalized care models is shaping market trends.